Inhibition of MEK/ERK1/2 Sensitizes Lymphoma Cells to Sorafenib-Induced Apoptosis

Leukemia Research - United Kingdom
doi 10.1016/j.leukres.2009.07.013
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

PARP Inhibition Sensitizes P53-Deficient Breast Cancer Cells to Doxorubicin-Induced Apoptosis

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2005English

Phosphatidylinositol 3-Kinase Inhibition Broadly Sensitizes Glioblastoma Cells to Death Receptor- And Drug-Induced Apoptosis

Cancer Research
Cancer ResearchOncology
2008English

Inhibition of Casein Kinase-2 Induces P53-Dependent Cell Cycle Arrest and Sensitizes Glioblastoma Cells to Tumor Necrosis Factor (TNFα)-induced Apoptosis Through SIRT1 Inhibition

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2012English

Downregulation of DcR3 Sensitizes Hepatocellular Carcinoma Cells to TRAIL-induced Apoptosis

OncoTargets and Therapy
OncologyPharmacology
2017English

Pharmacologic Inhibition of Fatty Acid Oxidation Sensitizes Human Leukemia Cells to Apoptosis Induction

Journal of Clinical Investigation
Medicine
2010English

Glycolysis Inhibition Targets McL-1 to Restore Sensitivity of Lymphoma Cells to ABT-737-induced Apoptosis

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2011English

MAPK/ERK Activation Sensitizes MKN-28 Cells to Cisplatin-Induced Apoptosis

Cancer Studies and Molecular Medicine - Open Journal
2015English

Mp72-08 Alternol Sensitizes Renal Carcinoma Cells to Trail-Induced Apoptosis

Journal of Urology
Urology
2018English

Brca2Deficiency Sensitizes Cells to PARP Inhibition

Cancer Research
Cancer ResearchOncology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy